Global Hormonal Contraceptive Market – Industry Trends & Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Jul 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Hormonal Contraceptive Market By Product (Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Transdermal Patches), Hormone (Androgens, Estrogens, Progestogens, Antiandrogens, Gonadotropins, Others), Age Group (15-24 Years, 25-34 Years, 35-44 Years, Above 44 Years), End- User (Hospitals, Household, Clinics, Gynecology Centers, Ambulatory Surgical Centers), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Hormonal Contraceptive Market

Global hormonal contraceptive market is set to witness a steady CAGR of 4.54% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing disposable income and large unmet contraceptive requirement are the major factor for the growth of this market.

Market Definition: Global Hormonal Contraceptive Market

Hormonal contraceptive are those which are used as a birth control method that usually work on endocrine systems. Some of the common hormonal contraceptives are emergency contraceptive pills, oral contraceptive pills, injectable birth control, transdermal patches and others. They usually act as a estrogen and progesterone during a women cycle with the help of synthetic hormones. Different methods are used and increasing cases of unwanted pregnancy is the factor fueling the growth of this market.

Market Drivers

  • Increasing demand to prevent unwanted pregnancy is the factor driving the market
  • Rising awareness about contraceptive worldwide will propel market
  • Technological advancement and development in contraceptive will also act as a driver for this market
  • Increasing initiatives by government and NGO will act as a driver

Market Restraints

  • Lack of acceptance by people will restrain the market
  • Increasing awareness about the health risk related with the use of contraceptive methods will also hamper market

Segmentation: Global Hormonal Contraceptive Market

By Product

  • Oral Contraceptive Pills
  • Injectable Birth Control
  • Emergency Contraceptive Pills
  • Vaginal Rings
  • Transdermal Patches

By Hormone

  • Androgens
  • Estrogens
  • Progestogens
  • Antiandrogens
  • Gonadotropins
  • Others

By Age Group

  • 15-24 Years
  • 25-34 Years
  • 35-44 Years
  • Above 44 Years

By End- User

  • Hospitals
  • Household
  • Clinics
  • Gynecology Centers
  • Ambulatory Surgical Centers

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Rest of South America

  • Europe

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific

  • Middle East & Africa

    • South Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In September 2017, The Ministry of Health and Family Welfare announced the launch of their two new contraceptive MPA under their program Antara and a contraceptive pill Chayya The main of the launch is to increase the contraceptive choices so that they can meet the rising need of the couples and will be useful for the women so that they can plan their pregnancies. Ministry has also launches software called Family Planning Logistics Management Information System so that they can improve the distribution and supply of the contraceptive.
  • In February 2015, Mylan Inc. announced that they have acquired Famy Care Limited so that they can expand their business in North America, Europe and Australia. This acquisition will help the company to expand their women healthcare portfolio and provide high quality medicines to their customers. The main aim is to strengthen their market position and expand their business worldwide.

Competitive Analysis:

Global hormonal contraceptive market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of hormonal contraceptive market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the global hormonal contraceptive market are Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd., Piramal Enterprises, Pfizer, Inc., Novartis AG, Lupin Pharmaceuticals, Inc., Glenmark Pharmaceuticals, Cipla Inc., Bayer AG, Amgen Inc, HLL Lifecare, f Merck & Co., Inc, Afaxys, Inc, Agile Therapeutics, Reckitt Benckiser, Boehringer Ingelheim International GmbH, V-Care Pharma Pvt. Ltd., Apothecus Inc.

Research Methodology: Global Hormonal Contraceptive Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global hormonal contraceptive market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE